PHS
MRTX
PFM Health Sciences’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-318,948
| Closed | -$11.9M | – | 86 |
|
|
2023
Q1 | $11.9M | Buy |
+318,948
| New | +$11.9M | 0.52% | 54 |
|
|
2022
Q1 | – | Sell |
-315,449
| Closed | -$46.3M | – | 78 |
|
|
2021
Q4 | $46.3M | Buy |
315,449
+14,904
| +5% | +$2.19M | 1.58% | 27 |
|
|
2021
Q3 | $53.2M | Buy |
300,545
+13,499
| +5% | +$2.39M | 1.56% | 23 |
|
|
2021
Q2 | $46.4M | Sell |
287,046
-22,734
| -7% | -$3.67M | 1.45% | 26 |
|
|
2021
Q1 | $53.1M | Buy |
309,780
+100,774
| +48% | +$17.3M | 1.62% | 19 |
|
|
2020
Q4 | $45.9M | Sell |
209,006
-40,062
| -16% | -$8.8M | 1.61% | 19 |
|
|
2020
Q3 | $41.4M | Buy |
+249,068
| New | +$41.4M | 1.91% | 16 |
|
|
2019
Q4 | – | Sell |
-431,123
| Closed | -$33.6M | – | 81 |
|
|
2019
Q3 | $33.6M | Buy |
+431,123
| New | +$33.6M | 0.99% | 38 |
|
|
2019
Q2 | – | Sell |
-120,166
| Closed | -$8.81M | – | 101 |
|
|
2019
Q1 | $8.81M | Buy |
+120,166
| New | +$8.81M | 0.19% | 75 |
|